NCT06194409 The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.
| NCT ID | NCT06194409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Infective Endocarditis |
| Study Type | OBSERVATIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-05-05 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 46 participants in total. It began in 2024-05-05 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to describe the incidence of IVDA among patients presented with IE, describe their clinical, psychiatric and microbiological characteristics in comparison to non - IVDA, as well as the rate and types of complications and outcome, and responsiveness to medical treatment or surgical intervention.
Eligibility Criteria
Inclusion Criteria: * Adult Patients (\>18 years) with definite or possible IE. Exclusion Criteria: * Patients with rejected diagnosis of infective endocarditis after workup, according to modified Duke's criteria.
Contact & Investigator
Yehia Kish
STUDY DIRECTOR
Assiut University
Frequently Asked Questions
Who can join the NCT06194409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infective Endocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06194409 currently recruiting?
Yes, NCT06194409 is actively recruiting participants. Contact the research team at peteralaa391@gmail.com for enrollment information.
Where is the NCT06194409 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06194409 clinical trial?
NCT06194409 is sponsored by Assiut University. The principal investigator is Yehia Kish at Assiut University. The trial plans to enroll 46 participants.